NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund small businesses undertaking projects to develop new molecular or cellular analysis tools for use in cancer research and clinical care, according to a new funding announcement.

These Small Business Innovation Research grants will fund R&D projects under NCI's Innovative Molecular Analysis Technology (IMAT) program, which supports early-stage development and validation of high-risk, high-payoff tools that improve the molecular or cellular analysis of cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.